Article Information
PMID
Published By
Print ISSN
0250-7005
Online ISSN
1791-7530
History
- Received August 29, 2003
- Revision received February 18, 2004
- Accepted April 1, 2004
- Published online May 1, 2004.
Copyright & Usage
Copyright© 2004 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
Author Information
- EIICHI ISHIKAWA1,2,
- KOJI TSUBOI1,
- KAORU SAIJO2,
- HIDEKI HARADA2,
- SHINGO TAKANO1,
- TADAO NOSE1 and
- TADAO OHNO2
- 1Department of Neurosurgery, Institute of Clinical Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba Science City, Ibaraki 305-8575
- 2RIKEN Cell Bank, The Institute of Physical and Chemical Research (RIKEN), 3-1-1 Koyadai, Tsukuba Science City, Ibaraki 305-0074, Japan
- Correspondence to: Tadao Ohno, Ph.D., RIKEN Cell Bank, RIKEN (The Institute of Physical and Chemical Research), 3-1-1 Koyadai, Tsukuba Science City, Ibaraki 305-0074, Japan. Tel: +81-298-36-9124, Fax: +81-298-36-9049, e-mail: tad-ohno{at}rtc.riken.go.jp
Statistics from Altmetric.com
Cited By...
In this issue
Jump to section
Related Articles
Cited By...
- Immune Escape After Adoptive T-cell Therapy for Malignant Gliomas
- Engineering the TGF{beta} Receptor to Enhance the Therapeutic Potential of Natural Killer Cells as an Immunotherapy for Neuroblastoma
- NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma
- Identification of a Natural Killer Cell Receptor Allele That Prolongs Survival of Cytomegalovirus-Positive Glioblastoma Patients
- Improvement of Impaired Immunological Status of Patients with Various Types of Advanced Cancers by Autologous Immune Cell Therapy
- Ex Vivo Expansion of Highly Cytotoxic Human NK Cells by Cocultivation with Irradiated Tumor Cells for Adoptive Immunotherapy